SCICLONE PHARMACEUTICALS INC — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/fb33d64b-3e3a-4237-899a-e60feaf08476/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2016 | $155.9M | 2016-01-01 – 2016-12-31 | evidence 0000880771-17-000035 |
| FY 2015 | $154.3M | 2015-01-01 – 2015-12-31 | evidence 0000880771-16-000135 |
| FY 2014 | $132.0M | 2014-01-01 – 2014-12-31 | evidence 0000880771-15-000021 |
| FY 2013 | $99.4M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-102095 |
| FY 2012 | $123.2M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-136952 |
| FY 2011 | $112.0M | 2011-01-01 – 2011-12-31 | evidence 0001193125-13-136952 |
| FY 2010 | $85.1M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-117370 |
| FY 2009 | $72.4M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-117370 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SCICLONE PHARMACEUTICALS INC — all facts · Net Income · Operating Income